Various 4-amino-5-mercapto-1,2,4-triazoles and their derivatives are associated with diverse pharmacological activities such as antibacterial\[[@ref1][@ref2]\], antifungal\[[@ref1]--[@ref3]\], antituberculosis\[[@ref3][@ref4]\], antiinflammatory\[[@ref5][@ref6]\], analgesic\[[@ref2]--[@ref7]\], anticonvulsant\[[@ref8]\], antiviral\[[@ref4]--[@ref9]\] and antitumor activities\[[@ref4]\]. Sulfonamides were the first effective chemotherapeutic agent to be employed systematically for the prevention and cure of bacterial infection in human as broad spectrum antimicrobials. Sulphonamides have been also reported as, antidiabetic\[[@ref10]\], antipyretic\[[@ref11]\] and plant growth retarding agent\[[@ref12]\].

Encouraged by these observation and by the established pharmacological activities of 1,2,4-triazoles, it was contemplated to incorporate the biologically active 'sulfonamide moiety' at the 3^rd^ position of 1,2,4-triazole ring, with a hope of obtaining triazoles with improved pharmacological activities. To enable further evaluation of the potential usefulness of 1,2,4-triazoles and in continuation of our search for 1,2,4-triazoles as pharmacologically active heterocycles\[[@ref5][@ref6]\], we report here in the synthesis of some new 3-β-\[(N-benzenesulphonyl/tosyl)-4-(un) substituted anilino\]ethyl-4-amino-5-mercapto-4(H)-1,2,4-triazoles (5a-f) with a view to achieve better antiinflammatory activity and least ulcerogenecity. All the compounds were evaluated for antimicrobial activities against *Escherichia coli, Bacillus cirroflagellosus, Aspergillus niger* and *Colletotrichum capsici*. The same compounds were evaluated for antituberculosis activity against *Mycobacterium tuberculsosis* H37Rv strain. The parent triazoles were evaluated for pharmacological activities such as antiinflammatory, analgesic, ulcerogenecity and anticonvulsant activities. The synthetic route for the title compounds is depicted as [fig. 1](#F1){ref-type="fig"}.

![Synhesis of 3-β-\[(N-benzenesulphonyl/tosyl)-4-(un)substituted aniline\]ethyl-4amino-5mercapto-4(H)-1,2,3-triazoles (5a-f) R~1~ = H, CH~3~ and Cl; R~2~ = H, CH~3~](IJPhS-73-115-g001){#F1}

In the present investigation, methyl β-\[(N-benzenesulphonyl/tosyl)-4-(un)substituted anilino\] propionates (2a-f) were prepared according to literature methods\[[@ref6][@ref13]\]. Esters (2a-f), when refluxed with hydrazine hydrate yielded the corresponding hydrazides (3a-f). Potassium β-\[(N-benzenesulphonyl/tosyl)-4-(un)substituted anilino\]propionyl dithiocarbazinates (4a-f), were obtained by stirring hydrazides (3a-f) with alcoholic potassium hydroxide and carbon disulphide. Potassium salts (4a-f), on reaction with two fold excess of hydrazine hydrate yielded 3-β-\[(N-benzenesulphonyl/tosyl)-4-(un)substituted anilino\]ethyl-4-amino-5-mercapto-4(H)-1,2,4-triazoles (5a-f). The structures of the newly synthesised compounds were confirmed by elemental and spectral (IR, ^1^H-NMR and mass) analysis. The physicochemical properties are enumerated in [Table 1](#T1){ref-type="table"}.

###### 

PHYSICOCHEMICAL PROPERTIES OF HYDRAZIDES 3a-f AND 1,2,4-TRIAZOLES 5a-f
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Melting points were determined in open capillaries and are uncorrected. IR spectra in KBr, were recorded on a Perkin Elmer spectrophotometer and ^1^H-NMR spectra on a Varian 300 MHz NMR spectrometer using TMS as an internal standard (chemical shifts in δ ppm). Mass spectra were recorded on Finnigan MAT 8230 mass spectrometer. The starting materials, methyl β-\[N-benzenesulphonyl/tosyl)-4-(un) substituted anilino\]propionates (2a-f) were prepared according to literature methods\[[@ref6][@ref13]\].

Sulphonylation of propionates (2a-f), was carried out by adding benzenesulphonylchloride (8.8 g, 0.05 mol) drop wise with cooling to a stirred solution of methyl-β-anilino propionate (0.05 mol) in dry benzene (10 ml) and pyridine (5.9 g, 0.075 mol). Reaction mixture was stirred for 48 h ([fig. 1](#F1){ref-type="fig"}). The reaction mixture was diluted with water and extracted with ether. The ethereal layer was washed with 10% hydrochloric acid, followed by 5% aqueous potassium hydroxide, water and a saturated solution of sodium chloride. The ether layer was then dried over anhydrous sodium sulphate and the solvent was removed under reduced pressure to get the sulphonylated ester (2a-f).

β-\[(N-benzenesulphonyl/tosyl)-4-(un)substituted anilino\]propionic acid hydrazides (3a-f), were prepared by refluxing a mixture of methyl, β-\[(N-benzene sulphonyl)anilino\]propionates(2a-f), (0.05 mol), hydrazine hydrate 99% (2.25 g, 0.05 mol) in ethyl alcohol (50 ml) for 6-8 h. Concentration in vacuum left a residue, which was poured onto crushed ice. The solid separated was filtered, washed with water, dried and crystallised from ethyl alcohol (3a-f). Physicochemical properties of same compounds are enumerated in [Table 1](#T1){ref-type="table"}. 3d IR (KBr) υ cm^-1^: 3500 (s), 3340 (m) (NH~2~), 3110 (b) (NH), 2990 (m) (CH~2~), 1730 (s), 1560 (m) (\>C=O), 1390 (s) (SO~2~); 3e: IR (KBr) υ cm^-1^: 3580 (s), 3320 (m) (NH~2~), 3060 (b) (NH), 2930 (m) (CH~2~), 1640 (s), 1600 (m) (\>C=O), 1400 (m) (SO~2~). ^1^HNMR: (DMSO-d~6~): 3b : δ 2.41 (t, 2H, -CH~2~-), 2.50 (s, 3H, CH~3~), 3.86 (t, 2H, -N-CH~2~-), 4.6 (s, 2H, NH~2~), 7.00-7.62 (m, 9H, ArH), 8.4 (s, 1H, NH). 3d: δ 2.33 (t, 2H, -CH~2~-), 2.36 (s, 3H, CH~3~), 2.42 (s, 3H, CH~3~), 3.80 (t, 2H, -N-CH~2~-), 4.5 (s, 2H, NH~2~), 6.88-7.48 (m, 8H, ArH), 8.5 (s, 1H, NH).

General procedure for preparation of potassium β-\[(N-benzenesulphonyl/tosyl)-4-(un)substituted anilino\]propionyl dithiocarbazinates (4a-f), involved the addition of carbon disulphide (2.28 g, 0.03 mol) drop wise to a clear solution of potassium hydroxide (1.68 g, 0.03 mol) in absolute ethanol (15 ml) and β-\[(N-benzenesulphonyl/tosyl)-4-(un)substituted anilino\]propionic acid hydrazide (3a-f) (0.02 mol) with stirring and cooling in ice. The reaction mixture was stirred continuously for 12 h and diluted with anhydrous ether (200 ml). The potassium dithiocarbazinate that separated was filtered, washed several times with anhydrous ether and dried in vacuum. The potassium salt(s) (4a-f) obtained in quantitative yield, were moisture sensitive and hence used directly for the preparation of the corresponding triazoles without further purification.

3-β-\[(N-benzenesulphonyl/tosyl)-4-(un)substitutedanilino\]ethyl-4-amino-5-mercapto-4(H)-1,2,4-triazoles (5a-f), were prepared by refluxing a clear solution of potassium salts of β-\[(N-benzenesulphonyl/tosyl)-4-(un)substituted anilino)propionyl dithiocarbazinates (4a-f), (0.02 mol) in water (10 ml) and hydrazine hydrate 99% (2.0 g, 0.04 mol) for 5-6 h. The color of the mixture turned to green with the evolution of hydrogen sulphide gas (lead acetate paper test and odor). The clear solution was treated with decolorising charcoal, filtered, cooled in ice and then carefully acidified with acetic acid. The precipitated solid was filtered, washed with water, dried and crystallised from ethanol. 5b, IR (KBr) υ cm^-1^: 3500 (s), 3210 (m) (NH~2~), 3000 (b) (NH), 2850 (s) (CH~2~), 1650 (s), 1540 (m (\>C=C\<, \>C=N-) 1430 (m) (\>C-N), 1190 (s), 1120 (m), (\>C=S), 1390 (s) (SO~2~); 5b: ^1^HNMR (DMSO-d~6~): δ 2.05 (t, 2H, -CH~2~), 2.42 (s, 3H, CH~3~), 3.99 (t, 2H, -N-CH~2~-), 4.61 (s, 1H, NH~2~), 10.59 (br.s, 1H, NH-C=S), 7.00-7.48 (m, 8H, ArH). 5b: MS: (m/z, Rel.Abund): 389 (M+, 10), 260 (56), 248 (12), 155 (82), 106 (22), 91 (100), 78 (18). 5c: ^1^HNMR: (DMSO-d~6~): δ 2.34 (s, 3H, CH~3~), 2.94 (t, 2H, -CH~2~-), 3.98 (t, 2H, -N-CH~2~-), 4.62 (s, 2H, NH~2~), 10.81 (br.s, 1H, NH-C=S), 6.89-7.61 (m, 8H, ArH). 5d: MS: (m/z, Rel. Abund): 404 (15), 285 (60), 250 (20), 160 (90), 125 (20), 106 (100), 91 (90), 78 (20). 5e: IR (KBr) υ cm^-1^: 3510 (s), 3210 (m) (NH~2~), 3010 (b) (NH), 2910 (m) (CH~2~), 1670 (s), 1620 (m) (\>C=C\<, \>C=N-) 1490 (m) (\>C-N), 1230 (s), 1100 (m), (\>C=S), 1430 (s) (SO~2~). Physicochemical properties are enumerated in [Table 1](#T1){ref-type="table"}.

After establishing the physicochemical properties of triazoles (5a-f), the compounds were subjected to pharmacological screening. Newly synthesised triazoles 5a-f, were first subjected for acute toxicity study in order to determine their, LD~50~. The study was carried out according to the method of Miller and Tainter\[[@ref14]\]. The graphically calculated LD~50~ values of the newly synthesised compounds were found to be 2238±34.3 (5a-d), 1849±23.1 (5e-f).

The antiinflamatory activity of triazoles 5a-f, was studied by carrageenan-induced rat paw edema method due to Winter *et al*\[[@ref15]\], cotton pellet induced granulation tissue formation method due to Meir, *et al*.\[[@ref16]\] and adrenal weight change method. To determine the severity of the ulcers, an arbitrary scoring system\[[@ref17]\] was followed. Analgesic activity of triazoles 5a-f, was carried out by radiant heat induced rat tail flick method\[[@ref18]\]. Anticonvulsant activity was studied by MES method\[[@ref19][@ref20]\]. The percentage protections were then assessed by Fischer\'s exact test\[[@ref21]\].

All the compounds were evaluated for antimicrobial activities against Gram negative bacterium E*scherichia coli*, Gram positive bacterium *Bacillus cirroflagellosus*, and fungi *Aspergillus niger* and *Colletotrichum capsici* by cup plate method\[[@ref22]\]. Antimicrobial activity is calculated as relative percent inhibition (with reference to the standard). DMF was used as solvent control. Cotrimoxazole (Trimethoprim 500 mg and Sulphamethoxazole 800 mg) and Diflucan (Flucanazole) are used as standards for antibacterial and antifungal respectively. Antimicrobial activity is expressed as relative percent inhibition in comparison with the standard.

Some of the newly synthesised compounds were tested for their antituberculosis activity against *M. tuberculosis* H37Rv by Bactec 460 radiometric system at Southern Research Institute, Frederick Research Center, Frederick MD. All the compounds were tested at a concentration of 12.5 μg/ml. Rifampicin was used as standard (97%, at 12.5 μg/ml).

In the carrageenan-induced rat paw edema method all the compounds exhibited moderate degree of antiinflammatory activity in comparison to the aspirin, 5b (75.80%, 65.60%, 57.60%), 5c (-, 69.63%, 67.60) and 5e (43.56, 51.40%, 67.58%), in comparison with the aspirin (54.84%, 55.05%, 73.81%) after 1, 3 and 6 h respectively. However remaining compounds 5d and 5f exhibited minimum antiinflammatory activity (19--32.66%), ([Table 2](#T2){ref-type="table"}). The same triazoles, however exhibited antiinflammatory activity (53.81-43.54) in the cotton pellet method better than the aspirin (41.88), except compound 5f (33.16). This has been further substantiated by the fact that the suppression of the adrenal weights of majority of the compounds are comparable (51.53-45.37) with that of the standard, aspirin (50.13%), except compound 5b (13.84), [Table 2](#T2){ref-type="table"}. During the present investigation all the triazoles except 5c (ulcer index, 40.00), have shown lesser degree (10--23.33) of ulcerogenecity, as compared to the aspirin (43.33), [Table 2](#T2){ref-type="table"}.

###### 

PHARMACOLOGICAL ACTIVITIES OF 3-β-\[(N-BENZENESULPHONYL/ TOSYL)-4-(UN)SUBSTITUTED ANILINO\] ETHYL-4-AMINO-5-MERCAPTO-4(H)-1,2,4,-TRIAZOLES (5A-F)
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In the radiant heat-induced rat tail flick method, all the compounds have exhibited most significant analgesic activity (*P*\<0.001) in comparison with the aspirin (49.39, *P*\<0.01) and the activity given in their decreasing order is 5d (120.72%), 5a (113.32), 5b (105.24), 5e (96.5), 5f (93.81) and 5c (81.02), ([Table 2](#T2){ref-type="table"}). In the maximum electroshock seizure MES method, only compound 5e has shown a moderate protection of 66% in comparison with the standard sodium phenytoin (100%). Compounds 5c and 5f exhibited 33% protection. Rest of the compounds failed to protect from MES, ([Table 2](#T2){ref-type="table"}).

Amongst all the compounds tested (3a-f) and (5a-f), majority have exhibited greater antifungal activity against *Colletotrichum capsici*. Antifungal activity, expressed as relative percent inhibition given in parentheses is enumerated in the decreasing order is 3f, 5a (544.44), 3c (439.39), 3d (302.00), 3e, 5f (206.06), 5b, 5c (126.94), 5d (64.65) and 3b (19.19), ([Table 3](#T3){ref-type="table"}). However the same compounds exhibited minimum antifungal activity (14--29%) against *Aspergillus niger*, except compounds 5a (158.56), 5c (78.76) and 5d (72.20) ([Table 3](#T3){ref-type="table"}). All the compounds exhibited minimum antibacterial activity (14--57.8%) against *Bacillus cirroflagellosus*. Some of the compounds 3e (100), 5c (73.67), 5b, 5d (51.11), 3a , 3b (41.25) have shown moderate antibacterial activity against *Escherichia coli*. Rests have shown minimum activity ([Table 3](#T3){ref-type="table"}). Only two compounds 5e (67) and 3f (59) exhibited moderate antituberclosis activity in comparison to the standard Rifampicin which has 97% at 12.5 μg/ml. All the remaining compounds exhibited minimum antituberculosis activity (16-48%) against, *M. tuberculosis H37Rv*, ([Table 3](#T3){ref-type="table"})

###### 

ANTIMICROBIAL AND ANTITUBERCULAR ACTIVITY OF HYDRAZIDES 3a-f AND 1,2,4-TRIAZOLES 5a-f
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